Bellevue Healthcare Trust plc
BBH.L · LSE
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.04 | 0.11 | -0.21 |
| FCF Yield | -0.93% | -1.57% | -5.76% | -0.73% |
| EV / EBITDA | 4.85 | -5.42 | -26.79 | 10.72 |
| Quality | ||||
| ROIC | 17.53% | -14.38% | -2.43% | 7.82% |
| Gross Margin | 104.33% | 81.58% | 90.93% | 94.20% |
| Cash Conversion Ratio | – | 0.09 | 1.00 | -0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -36.60% | -13.94% | 56.86% |
| Free Cash Flow Growth | 45.46% | 73.22% | -501.83% | -56.33% |
| Safety | ||||
| Net Debt / EBITDA | -3.56 | 0.68 | -1.32 | 0.43 |
| Interest Coverage | 42.48 | -33.03 | -9.46 | 188.60 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.07 | 0.20 | 0.00 |
| Cash Conversion Cycle | -14,258.22 | 5,063.35 | 1,736.57 | -345.49 |